Orion Portfolio Solutions, LLC Reata Pharmaceuticals Inc Transaction History

Orion Portfolio Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $396 - $526	5 Added 0.19%	2,682 $273,000
Q1 2023 Aug 30, 2023	SELL	$30.85 - $93.17 $154 - $465	-5 Reduced 0.19%	2,677 $243,000
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $82,585 - $249,416	2,677 New	2,677 $243,000
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $993 - $1,981	-8 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $596 - $1,743	8 New	8 $2,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.